Results 211 to 220 of about 21,002 (228)
Some of the next articles are maybe not open access.
Pharmacoeconomics of antifungal pharmacotherapy – challenges and future directions
Expert Opinion on Pharmacotherapy, 2005Melissa D. Johnson
exaly
Pharmacoeconomics – an aid to better decision-making
Journal of the European Academy of Dermatology and Venereology, 2005Antonella Tosti, Eckart Haneke
exaly
Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia
Expert Review of Pharmacoeconomics and Outcomes Research, 2012Allison Krug, Leon E Cosler
exaly
Pharmacoeconomics Education in US Colleges and Schools of Pharmacy
American Journal of Pharmaceutical Education, 2013Karen Rascati, Tatiana Makhinova
exaly
Interventional Pharmacoeconomics—A New Discipline for a Cost-Constrained Environment
JAMA Oncology, 2019Mark J Ratain, Daniel A Goldstein
exaly
Bayesian approach in pharmacoeconomics: relevance to decision-makers
Expert Review of Pharmacoeconomics and Outcomes Research, 2003Ya-Chen Tina Shih
exaly
Pharmacoeconomics in the years of crisis: a solution or just a resolution? A Cyprus perspective
Expert Review of Pharmacoeconomics and Outcomes Research, 2014Panagiotis Petrou
exaly
The Pharmacoeconomics of Breakthrough Cancer Pain
Journal of Pain and Palliative Care Pharmacotherapy, 2013Surasak Saokaew, David D Stenehjem
exaly
Pharmacoeconomics of antipsychotic medications
Expert Review of Pharmacoeconomics and Outcomes Research, 2002Susan M Essock, Ellen M Weissman
exaly

